Mounjaro for Diabetes: How Tirzepatide Lowers A1c and Blood Sugar
A complete guide to Mounjaro for type 2 diabetes, including how tirzepatide works, clinical results, dosing, side effects, and how to get a prescription.
Start your GLP-1 weight-loss plan today
Get matched with a US telehealth provider, approved online, and have medication shipped to your door.
Check my eligibilityAvailable online. Shipped directly to your door anywhere in the US.
What is Mounjaro?
Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication approved by the FDA to treat type 2 diabetes. It is a dual GIP and GLP-1 receptor agonist, meaning it targets two hormones that help regulate blood sugar and appetite.
Mounjaro is also used off-label for weight loss because it produces substantial weight reduction. However, its FDA-approved indication is for type 2 diabetes.
How does Mounjaro work for diabetes?
Tirzepatide works by mimicking two natural hormones:
- GLP-1: Stimulates insulin release when blood sugar is high, reduces glucagon, and slows stomach emptying.
- GIP: Enhances insulin secretion and supports fat and energy metabolism.
By acting on both receptors, tirzepatide lowers A1c more effectively than many other diabetes medications and also promotes weight loss.
How much does Mounjaro lower A1c?
In clinical trials, Mounjaro lowered A1c by an average of 1.8 to 2.4 percentage points depending on the dose. This is a significant reduction and often brings people closer to or below the A1c target of 7%.
Mounjaro dosing for diabetes
Mounjaro follows a step-by-step titration schedule:
- Start at 2.5 mg once weekly for 4 weeks
- Increase to 5 mg for at least 4 weeks
- Continue increasing by 2.5 mg every 4 weeks if needed
- Maximum approved dose is 15 mg weekly
Your provider will choose your target dose based on your A1c, weight, side effects, and goals.
Is Mounjaro better than Ozempic for diabetes?
In head-to-head trials, Mounjaro lowered A1c and produced more weight loss than Ozempic. However, both are effective options. The best choice depends on your insurance coverage, side effect tolerance, and cost.
Common side effects of Mounjaro
The most common side effects are digestive:
- Nausea
- Diarrhea
- Constipation
- Vomiting
- Decreased appetite
- Stomach pain
These symptoms are usually worse during dose increases and improve over time.
Who should take Mounjaro for diabetes?
Mounjaro may be appropriate for adults with type 2 diabetes who need better blood sugar control, especially those who also need to lose weight. It is often used when metformin or other first-line treatments are not enough.
It is not approved for type 1 diabetes and is not recommended for people with a history of pancreatitis or medullary thyroid carcinoma.
How much does Mounjaro cost?
The list price for Mounjaro is around $1,069 per month. With insurance or a manufacturer savings card, eligible patients may pay as little as $25 per month. Cash-paying patients may consider compounded tirzepatide through a licensed telehealth provider.
How to get Mounjaro for diabetes online
You can get Mounjaro prescribed online through licensed telehealth programs. The process usually includes:
- Complete an online health questionnaire
- Share recent A1c or lab results if available
- Speak with a licensed provider
- Receive a prescription if appropriate
- Get medication shipped to your home
Frequently asked questions
Can Mounjaro be my only diabetes medication?
Some people use Mounjaro alone, while others combine it with metformin or other diabetes medications. Your provider will design the right plan.
How long before Mounjaro lowers blood sugar?
Blood sugar improvements can begin within days, but A1c changes are usually measured after 3 months.
Do I need a diabetes diagnosis to get Mounjaro?
For insurance coverage, a type 2 diabetes diagnosis is usually required. Telehealth providers may evaluate you based on your medical history and lab results.
Can Mounjaro reverse type 2 diabetes?
Mounjaro can improve blood sugar control and reduce A1c significantly, but it does not cure diabetes. Lifestyle changes remain important.
Is Mounjaro the same as Ozempic?
No. Mounjaro is tirzepatide, a dual GIP/GLP-1 agonist. Ozempic is semaglutide, a single GLP-1 agonist. Tirzepatide generally produces more A1c and weight loss.
Conclusion
Mounjaro is a powerful option for people with type 2 diabetes who need better blood sugar control and weight management. Its dual mechanism of action helps lower A1c more than many other medications and supports significant weight loss.
Ready to see if Mounjaro is right for you? Get evaluated by a licensed US telehealth provider and have diabetes medication shipped to your door if approved.
Ready to take the next step?
Compare top US telehealth GLP-1 programs and start your medically supervised weight-loss journey.
Find my GLP-1 programAvailable online. Shipped directly to your door anywhere in the US.